ATE394111T1 - Lipoteichonsäure aus milchsäurebakterie zur verwendung als arzneimittel und zur behandlung von bakteriellen erkrankungen - Google Patents
Lipoteichonsäure aus milchsäurebakterie zur verwendung als arzneimittel und zur behandlung von bakteriellen erkrankungenInfo
- Publication number
- ATE394111T1 ATE394111T1 AT02742909T AT02742909T ATE394111T1 AT E394111 T1 ATE394111 T1 AT E394111T1 AT 02742909 T AT02742909 T AT 02742909T AT 02742909 T AT02742909 T AT 02742909T AT E394111 T1 ATE394111 T1 AT E394111T1
- Authority
- AT
- Austria
- Prior art keywords
- lactic acid
- bacteria
- acid bacteria
- relates
- treatment
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 8
- 241000894006 Bacteria Species 0.000 title abstract 5
- 239000002253 acid Substances 0.000 title abstract 4
- 235000014655 lactic acid Nutrition 0.000 title abstract 4
- 239000004310 lactic acid Substances 0.000 title abstract 4
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 2
- 208000034309 Bacterial disease carrier Diseases 0.000 abstract 1
- 241000192125 Firmicutes Species 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- 229940023486 oral product Drugs 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
- 229940025703 topical product Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/739—Lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01201958A EP1260227A1 (de) | 2001-05-23 | 2001-05-23 | Lipoteichonsäure aus Milchsäurebakterien sowie dessen Verwendung zur Modulierung der durch gram-negative, potenziell pathogene gram-positive Bakterien induzierte Immunantwort |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE394111T1 true ATE394111T1 (de) | 2008-05-15 |
Family
ID=8180365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02742909T ATE394111T1 (de) | 2001-05-23 | 2002-04-23 | Lipoteichonsäure aus milchsäurebakterie zur verwendung als arzneimittel und zur behandlung von bakteriellen erkrankungen |
Country Status (21)
Country | Link |
---|---|
US (3) | US20040147010A1 (de) |
EP (2) | EP1260227A1 (de) |
JP (1) | JP4738717B2 (de) |
KR (1) | KR20040018375A (de) |
CN (1) | CN100502888C (de) |
AT (1) | ATE394111T1 (de) |
AU (1) | AU2002338873B8 (de) |
BR (1) | BR0209975A (de) |
CA (1) | CA2449403C (de) |
DE (1) | DE60226436D1 (de) |
DK (1) | DK1395269T3 (de) |
ES (1) | ES2305256T3 (de) |
IN (1) | IN2003DE02242A (de) |
MX (1) | MX260807B (de) |
NO (1) | NO20035187L (de) |
PL (1) | PL366455A1 (de) |
PT (1) | PT1395269E (de) |
RU (1) | RU2320356C2 (de) |
SG (1) | SG101083A1 (de) |
WO (1) | WO2002094296A1 (de) |
ZA (1) | ZA200309821B (de) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2408573A (en) * | 2003-11-25 | 2005-06-01 | Univ Leicester | Assay for the interaction of L-Ficolin with lipoteichoic acid |
WO2005079210A2 (en) * | 2003-12-04 | 2005-09-01 | Biofilms Strategies, Inc. | Methods and compositions for preventing biofilm formations, reducing existing biofilms, and for reducing existing biofilms, and for reducing populations of bacteria |
JP3947778B2 (ja) * | 2003-12-05 | 2007-07-25 | 株式会社トーヨー技術研究所 | ハスの破砕物および/または抽出物と、乳酸菌とを含む抗アレルギー剤 |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US7510734B2 (en) | 2004-03-04 | 2009-03-31 | E-L Management Corporation | Skin treatment method with Lactobacillus extract |
US7862808B2 (en) * | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
JP4726109B2 (ja) * | 2005-02-10 | 2011-07-20 | 昭和電工株式会社 | 皮膚外用剤、それを用いる皮膚有害微生物の付着予防方法及び増殖防止方法 |
US7303745B2 (en) * | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
BRPI0611492B1 (pt) | 2005-05-31 | 2021-10-13 | Mars, Incorporated | Bifidobactéria probiótica felina |
WO2006130187A1 (en) | 2005-05-31 | 2006-12-07 | The Iams Company | Feline probiotic lactobacilli |
CN101711158A (zh) | 2007-02-01 | 2010-05-19 | 爱默思公司 | 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法 |
CA2680038A1 (en) * | 2007-03-08 | 2008-09-12 | The Governors Of The University Of Alberta | Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections |
US20080299098A1 (en) * | 2007-04-24 | 2008-12-04 | Chea-Yun Se | Broad-Spectrum Antibacterial and Antifungal Activity of Lactobacillus Johnsonii D115 |
JP5225652B2 (ja) * | 2007-10-29 | 2013-07-03 | 雪印メグミルク株式会社 | アディポネクチン分泌促進及び/又は減少抑制剤 |
US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
EP2140772A1 (de) * | 2008-07-03 | 2010-01-06 | Nestec S.A. | Temperaturinduzierte Verabreichung von Nährstoffen durch Mikroorganismen im Magen-Darm-Trakt |
US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
RU2011129693A (ru) * | 2008-12-16 | 2013-01-27 | Нестек С.А. | Композиции и способы улучшения здоровья полости рта |
RU2556124C2 (ru) * | 2009-05-11 | 2015-07-10 | Нестек С.А. | Lactobacillus johnsonii La1 NСС533 (CNCM 1-1225) И ИММУННЫЕ НАРУШЕНИЯ |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
CN102596980A (zh) * | 2009-08-26 | 2012-07-18 | Rna公司 | 源自脂磷壁酸的糖脂及含有该糖脂的组合物 |
JP2014506923A (ja) | 2011-03-01 | 2014-03-20 | クオラム イノベーションズ リミテッド ライアビリティ カンパニー | 病原性バイオフィルムと関連した状態を治療するための物質および方法 |
EP2680860A4 (de) | 2011-03-03 | 2014-08-20 | Univ Alberta | Verwendung von bakteriellen endotoxinen und lipoteichonsäuren für verbesserte postpartale gesundheit und produktivität von milchkühen und ihren neugeborenen |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
US20130089638A1 (en) * | 2011-10-11 | 2013-04-11 | Mead Johnson Nutrition Company | Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes |
EP2589387A1 (de) * | 2011-11-04 | 2013-05-08 | Lunamed AG | Verwendung einer Teichonsäure zur Behandlung von malignem Liquor cerebrospinalis im Gehirn |
CN102399733B (zh) * | 2011-12-14 | 2014-07-09 | 北京大北农科技集团股份有限公司 | 约氏乳杆菌及其菌剂、应用和预混料 |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
US9399048B2 (en) * | 2014-03-05 | 2016-07-26 | Asian Probiotics And Prebiotics Ltd | Lactic acid bacteria and its applications in immunomodulation and anti-inflammation |
CN104161776A (zh) * | 2014-05-29 | 2014-11-26 | 浙江大学宁波理工学院 | 来自丁酸梭菌的脂磷壁酸及其调节畜禽免疫应答的用途 |
CN104161775A (zh) * | 2014-05-29 | 2014-11-26 | 浙江大学宁波理工学院 | 来自丁酸梭菌的脂磷壁酸在调节水产动物免疫应答中的用途 |
LT3065748T (lt) | 2014-12-23 | 2018-03-12 | 4D Pharma Research Limited | Bacteroides thetaiotaomicron padermė ir jos panaudojimas uždegimo sumažinimui |
HUE037476T2 (hu) | 2014-12-23 | 2018-08-28 | 4D Pharma Res Ltd | Pirin polipeptid és immunmodulálás |
MX2017010321A (es) | 2015-02-13 | 2017-12-07 | Mars Inc | Sistema de alimentacion para mascotas. |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
EP3636272A1 (de) | 2015-06-15 | 2020-04-15 | 4D Pharma Research Limited | Zusammensetzungen mit bakterienstämmen |
RS59308B1 (sr) | 2015-06-15 | 2019-10-31 | 4D Pharma Res Ltd | Kompozicije koje sadrže bakterijske sojeve |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
LT3650033T (lt) | 2015-06-15 | 2022-04-11 | 4D Pharma Research Limited | Kompozicijos, apimančios bakterinius kamienus |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB2561748B (en) | 2015-11-20 | 2019-05-08 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
TW201733601A (zh) | 2016-03-04 | 2017-10-01 | 4D製藥有限公司 | 包含細菌菌株之組合物 |
AU2017240068B2 (en) | 2016-03-31 | 2022-12-15 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
JP2019510036A (ja) | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | プロバイオティクス/プレバイオティクス有効成分を含む清浄剤組成物 |
TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
CN106236826A (zh) * | 2016-08-12 | 2016-12-21 | 福建万亿店中店电子商务有限责任公司 | 一种用于***疾病辅助治疗的乳酸菌磷壁酸凝胶 |
EP3544575A1 (de) | 2016-11-23 | 2019-10-02 | GOJO Industries, Inc. | Desinfektionszusammensetzung mit probiotischem/präbiotischem wirkstoff |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
MA48940A (fr) | 2017-05-22 | 2020-04-08 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
EP3630942B1 (de) | 2017-05-24 | 2022-11-30 | 4D Pharma Research Limited | Zusammensetzungen mit bakterienstamm |
MD3638271T2 (ro) | 2017-06-14 | 2021-03-31 | 4D Pharma Res Ltd | Compoziții cuprizând tulpini bacteriene |
DK3804737T3 (da) | 2017-06-14 | 2022-07-25 | 4D Pharma Res Ltd | Sammensætninger omfattende bakteriestammer |
KR102205829B1 (ko) * | 2017-06-14 | 2021-01-21 | 기초과학연구원 | 신규한 비피도박테리움 비피덤 균주 및 균주 유래 다당체 |
US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
CN111053789A (zh) * | 2019-11-26 | 2020-04-24 | 湖南营养树生物科技有限公司 | 调节免疫***的方法和组合物 |
CN115279380A (zh) * | 2019-12-27 | 2022-11-01 | 佰欧波利斯有限公司 | 来自双歧杆菌的脂磷壁酸的用途 |
KR102325947B1 (ko) * | 2020-02-05 | 2021-11-15 | 주식회사 에이치이엠파마 | 신규한 락토바실러스 사케이 hem224 균주, 및 상기 균주 또는 이의 배양물을 포함하는 염증 또는 천식의 치료용 조성물 |
JP2023179810A (ja) * | 2020-11-13 | 2023-12-20 | 味の素株式会社 | ラクトコッカス・ラクチス、ラクトバチルス属に属する微生物、又はこれらの混合微生物を含有する生菌剤及びその製造方法 |
JP2023128590A (ja) * | 2022-03-03 | 2023-09-14 | 株式会社アルソア慧央グループ | 腸管免疫賦活剤、IgA産生促進剤及び遺伝子発現促進剤 |
CN115068510A (zh) * | 2022-05-24 | 2022-09-20 | 宁波大学 | 一种乳杆菌脂磷壁酸的提取方法及其抗炎活性应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6048929A (ja) * | 1983-08-26 | 1985-03-16 | Chugai Pharmaceut Co Ltd | 抗腫瘍剤 |
US4678773A (en) * | 1983-08-26 | 1987-07-07 | Chugai Seiyaku Kabushiki Kaisha | Antitumor agent |
JPS6048928A (ja) * | 1983-08-26 | 1985-03-16 | Chugai Pharmaceut Co Ltd | Tνf誘起剤 |
JPS61275217A (ja) * | 1985-05-29 | 1986-12-05 | Yakult Honsha Co Ltd | グラム陰性桿菌感染症防御剤 |
US5804179A (en) * | 1985-12-31 | 1998-09-08 | Research Corporation Technologies, Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
DE3817762A1 (de) * | 1988-05-26 | 1989-11-30 | Sanum Kehlbeck Gmbh & Co Kg | Immunstimulierendes mittel aus propionibakterien sowie verfahren zur herstellung desselben |
ES2111625T3 (es) * | 1992-07-06 | 1998-03-16 | Nestle Sa | Agente antigastritis. |
WO1994020115A2 (en) * | 1993-03-10 | 1994-09-15 | Miles, Inc. | Hyaluronic acid used as a cancer treatment |
US6180100B1 (en) * | 1994-09-30 | 2001-01-30 | Urex Biotech., Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
JP3489930B2 (ja) * | 1996-03-08 | 2004-01-26 | 株式会社ヤクルト本社 | がん予防食品 |
DE69733594T2 (de) * | 1996-07-09 | 2005-11-03 | Société des Produits Nestlé S.A. | Verfahren zur Sprühtrocknung |
PT862863E (pt) * | 1997-01-09 | 2002-04-29 | Nestle Sa | Produto cerealifero contendo probioticos |
US5998482A (en) * | 1997-11-10 | 1999-12-07 | David; Sunil A. | Use of synthetic polycationic amphiphilic substances with fatty acid or hydrocarbon substituents as anti-sepsis agents |
JP3046303B1 (ja) * | 1999-06-24 | 2000-05-29 | 明治乳業株式会社 | Helicobacterpylori除菌性飲食品 |
DE19963420A1 (de) * | 1999-12-28 | 2001-07-12 | Sebo Gmbh | Gewinnung von biologischen Komponenten aus Körperflüssigkeiten |
-
2001
- 2001-05-23 EP EP01201958A patent/EP1260227A1/de not_active Withdrawn
-
2002
- 2002-04-23 KR KR20037015185A patent/KR20040018375A/ko not_active Application Discontinuation
- 2002-04-23 RU RU2003136828/15A patent/RU2320356C2/ru not_active IP Right Cessation
- 2002-04-23 MX MXPA03010598 patent/MX260807B/es active IP Right Grant
- 2002-04-23 DK DK02742909T patent/DK1395269T3/da active
- 2002-04-23 SG SG200306895A patent/SG101083A1/en unknown
- 2002-04-23 PL PL02366455A patent/PL366455A1/xx not_active IP Right Cessation
- 2002-04-23 US US10/478,079 patent/US20040147010A1/en not_active Abandoned
- 2002-04-23 AU AU2002338873A patent/AU2002338873B8/en not_active Ceased
- 2002-04-23 PT PT02742909T patent/PT1395269E/pt unknown
- 2002-04-23 ES ES02742909T patent/ES2305256T3/es not_active Expired - Lifetime
- 2002-04-23 BR BR0209975-6A patent/BR0209975A/pt not_active Application Discontinuation
- 2002-04-23 CA CA2449403A patent/CA2449403C/en not_active Expired - Fee Related
- 2002-04-23 JP JP2002591013A patent/JP4738717B2/ja not_active Expired - Fee Related
- 2002-04-23 WO PCT/EP2002/004436 patent/WO2002094296A1/en active IP Right Grant
- 2002-04-23 EP EP02742909A patent/EP1395269B1/de not_active Expired - Lifetime
- 2002-04-23 AT AT02742909T patent/ATE394111T1/de active
- 2002-04-23 DE DE60226436T patent/DE60226436D1/de not_active Expired - Lifetime
- 2002-04-23 CN CNB02810479XA patent/CN100502888C/zh not_active Expired - Fee Related
-
2003
- 2003-11-21 NO NO20035187A patent/NO20035187L/no not_active Application Discontinuation
- 2003-12-18 ZA ZA200309821A patent/ZA200309821B/xx unknown
- 2003-12-23 IN IN2242DE2003 patent/IN2003DE02242A/xx unknown
-
2008
- 2008-10-07 US US12/246,991 patent/US8329190B2/en not_active Expired - Fee Related
-
2013
- 2013-08-15 US US13/967,936 patent/US20140056927A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PT1395269E (pt) | 2008-06-16 |
KR20040018375A (ko) | 2004-03-03 |
DK1395269T3 (da) | 2008-08-04 |
NO20035187L (no) | 2004-01-05 |
ZA200309821B (en) | 2005-03-18 |
US8329190B2 (en) | 2012-12-11 |
IN2003DE02242A (en) | 2006-01-20 |
ES2305256T3 (es) | 2008-11-01 |
US20090142375A1 (en) | 2009-06-04 |
JP2005500267A (ja) | 2005-01-06 |
PL366455A1 (en) | 2005-02-07 |
RU2003136828A (ru) | 2005-03-10 |
MX260807B (es) | 2008-09-25 |
JP4738717B2 (ja) | 2011-08-03 |
RU2320356C2 (ru) | 2008-03-27 |
CN100502888C (zh) | 2009-06-24 |
NO20035187D0 (no) | 2003-11-21 |
US20140056927A1 (en) | 2014-02-27 |
CA2449403A1 (en) | 2002-11-28 |
DE60226436D1 (de) | 2008-06-19 |
CN1525863A (zh) | 2004-09-01 |
EP1395269A1 (de) | 2004-03-10 |
BR0209975A (pt) | 2004-04-06 |
MXPA03010598A (es) | 2004-03-09 |
EP1395269B1 (de) | 2008-05-07 |
CA2449403C (en) | 2011-11-15 |
US20040147010A1 (en) | 2004-07-29 |
AU2002338873B2 (en) | 2008-04-10 |
WO2002094296A1 (en) | 2002-11-28 |
SG101083A1 (en) | 2006-02-28 |
AU2002338873B8 (en) | 2008-05-08 |
AU2002338873A1 (en) | 2002-12-03 |
EP1260227A1 (de) | 2002-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE394111T1 (de) | Lipoteichonsäure aus milchsäurebakterie zur verwendung als arzneimittel und zur behandlung von bakteriellen erkrankungen | |
CN105189732B (zh) | 预防和/或治疗与病原性细菌相关的感染、定植或疾病的方法 | |
CN105148253B (zh) | 皮肤黏膜抗菌组合物 | |
CA2688736C (en) | Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology | |
EA200200059A1 (ru) | Комбинация молочнокислых бактерий и ее применение для профилактики и/или лечения инфекций и воспалительных состояний | |
BG106825A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
NO20030316L (no) | Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker | |
WO2005058935A3 (en) | Aqueous suspensions of ciclesonide for nebulisation | |
ATE340561T1 (de) | Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen | |
BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
ATE454139T1 (de) | Arzneimittel mit shikonin als wirkstoff | |
Gichki et al. | HEALING EFFECTS OF NATURAL HONEY ON ORAL MINOR APTHOUS ULCERS AMONG DENTAL PATIENTS IN QUETTA. | |
ATE316379T1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
GB0114672D0 (en) | Pharmaceutical formulations and methods of medical treatment | |
JP2020015710A (ja) | 病原性微生物等やlps及びクオラムセンシングによる難病の予防改善治療の方法 | |
de Cássia Oliveira et al. | Bacteriophage Isolation from Denture Biofilm | |
DE60234031D1 (de) | Mittel zur behandlung allergischer augenerkrankungen | |
Koilybayeva et al. | The study of wound-healing actions of collagen membranes with probiotics for topical application | |
Lakshmi | In Vitro Bactericidal Activity of Herbal Extracts against Coagulase Positive Staphylococcus intermedius–A Common Oral Pathogen in Animal Species | |
CN111479569A (zh) | 氯唑西林抑制/预防生物膜形成的用途 | |
CA3170666A1 (en) | Composition for the prevention and treatment of dysbiosis | |
TW200701989A (en) | Health care composition for oral cavity and manufacturing method thereof | |
Romly | Established Apitheraphy Centre in Kelana Jaya, Selangor Malaysia. | |
Notari et al. | Ciprofloxacin: a study of usage in pedal infections with case reports | |
De Luca et al. | Research Article Propolis Varnish: Antimicrobial Properties against Cariogenic Bacteria, Cytotoxicity, and Sustained-Release Profile |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1395269 Country of ref document: EP |